Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1996
12/10/1996CA2104456C Pyridine- and imidazole-derived agents for cardiovascular diseases
12/10/1996CA2017285C Stabilized calcitonin pharmaceutical composition
12/08/1996CA2178414A1 Dihydropyridine npy antagonists: nitrogen heterocyclic derivatives
12/08/1996CA2178413A1 Dihydropyridine npy antagonists: piperazine derivatives
12/08/1996CA2178355A1 Diazepine containing dual action inhibitors
12/08/1996CA2178352A1 Thiazolo benzazepine containing dual action inhibitors
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178183A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2177110A1 Dihydropyridine npy antagonists: piperidine derivatives
12/08/1996CA2176854A1 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
12/07/1996CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives
12/05/1996WO1996038588A1 Analytical and therapeutic agents
12/05/1996WO1996038579A1 High-affinity oligonucleotide ligands to growth factors
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038548A1 Oxygen activatable formulations for disinfection or sterilization
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038436A1 (2-thienyl)alkanoic acid derivatives
12/05/1996WO1996038434A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038414A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/05/1996WO1996038162A1 Method of using lectins for prevention and treatment of skin diseases and disorders
12/05/1996WO1996038156A1 Use of alendronate for the prevention of osteoporosis
12/05/1996WO1996038154A1 Means for treating radiation injuries
12/05/1996WO1996038152A1 Method for treating anorexia
12/05/1996WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996WO1996038145A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996WO1996038143A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
12/05/1996WO1996038132A1 Method of altering the contents of eggs
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222573A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
12/05/1996CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2222539A1 Agent for the treatment of radiation injuries
12/05/1996CA2222318A1 Use of alendronate for the prevention of osteoporosis
12/05/1996CA2222292A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2222073A1 Method for treating anorexia
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2220040A1 Tricyclic inhibitors of matrix metalloproteinases
12/04/1996EP0745598A1 Piperazine, piperidine and 1,2,5,6-tetrahydropyridine derivatives, proces for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745596A1 Heteroaromatic oxazole compounds and use thereof
12/04/1996EP0745584A1 Arylalkyl(thio) carboxamides compounds with affinity for melatonine receptors, processes for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745583A1 Alkoxy aryl compounds with affinity to the melatonine receptors, process for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745384A2 Methods for inhibiting vascular smooth muscle cell migration
12/04/1996EP0745375A1 Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
12/04/1996EP0745372A1 Use of colloidal silicic acid to reinforce keratineous fibres
12/04/1996EP0745131A1 Targeting gene therapy
12/04/1996EP0745124A1 Mammalian cell cycle protein
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745091A1 Use of angiotensin ii analogs in tissue repair
12/04/1996EP0745083A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
12/04/1996EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0745079A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
12/04/1996EP0745077A1 Enantiomerically pure (+)-liarozole
12/04/1996EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a
12/04/1996EP0744954A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
12/04/1996EP0744950A1 Agent for prophylaxis and treatment of thromboxane a 2?-mediated diseases
12/04/1996EP0744944A1 Sexual steroid-containing transdermal therapeutic systems
12/04/1996EP0744943A1 Desogestrel-containing transdermal application agent
12/04/1996EP0485486B1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby
12/04/1996EP0440738B1 Treatment of hypertension
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1137267A N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid derivatives as chelating agents
12/04/1996CN1137040A New mercaptoalanoyldipeptide compounds process for their preparation and pharmaceutical compositions containign them
12/04/1996CN1137039A Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines
12/04/1996CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels
12/04/1996CN1136959A "Shuangzhuyuye" liquid-health beverage
12/04/1996CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions
12/03/1996US5580989 Antiallergens, antiinflammatory agents
12/03/1996US5580895 1,5-benzodiazepine derivatives
12/03/1996US5580892 Antidiarrhetic, antispastic, antiepileptic agents; diuretics
12/03/1996US5580888 Administering for therapy and prophylaxis of asthma; potent phosphodiesterase iv isoenzyme inhibitors
12/03/1996US5580885 5-HT4 receptor antagonists
12/03/1996US5580884 Antimicrobial agents
12/03/1996US5580878 Treating sleep disorders
12/03/1996US5580870 Quinazoline derivatives
12/03/1996US5580780 Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
12/03/1996US5580623 Reacting orthophosphoric acid under anhydrous condition with atleast one of calcium carbonate, calcium hydroxide and calcium phosphate to form rapidly setting calcium phophate mineral suitable for bone grafting
12/03/1996US5580543 Texaphyrins as radiation sensitizers
11/1996
11/28/1996WO1996037621A2 Multimeric proteins
11/28/1996WO1996037619A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
11/28/1996WO1996037608A1 Novel variants of apolipoprotein a-i
11/28/1996WO1996037514A1 Chimeric fatty body-pro-grf analogs with increased biological potency
11/28/1996WO1996037500A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
11/28/1996WO1996037492A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037488A1 Piperazine derivatives
11/28/1996WO1996037487A1 Process for producing thiazolidine derivatives
11/28/1996WO1996037485A1 2-amino-benzoxazinones for the treatment of viral infections
11/28/1996WO1996037223A1 Muscle trophic factor
11/28/1996WO1996037214A2 Compositions of interleukin and pyrimidine nucleosides
1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 1564